Susquehanna International Group, LLP Kura Oncology, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 171,448 shares of KURA stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,448
Previous 84,514
102.86%
Holding current value
$1.03 Million
Previous $736,000
53.67%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding KURA
# of Institutions
190Shares Held
79MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$46.4 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$44.5 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$41.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$39.3 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$29.6 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $400M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...